All extracted drugs
Showing 1,381–1,440 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Articles mentioning drugs
10,506 articles · page 163 of 876…2025).Aim and Objectives To describe the utilisation profile of ceftazidime-avibactam-aztreonam in the treatment of multidrug-resistant GNB infections.Material…
…nd corticosteroids, with relapses occurring in 20–50% of cases. Rituximab and caplacizumab (available since 2018) are currently used in c…
…tional Health Service in England (NICE) have recommended dosing pembrolizumab by weight.3 4 Aim and Objectives To assess the economic impact …
…iscontinued were J01XX group antibiotics (linezolid, tedizolid, daptomycin) (n=46), with an acceptance rate of 82.6% (n=38).De-escalation …
…tudy was conducted including all patients with MPN treated with ruxolitinib. Demographic, clinical, and disease evolution variables were co…
…implementation) and on day 3 in March 2024 (post-intervention). Antibiotics were categorised as Access, Watch, or Reserve according to the …
…the only without polysorbate). Consequently, desensitisation to tezepelumab was proposed.Results The content of the commercial pen (CP) (21…
…, 48.7% (19) started fluoropyrimidines: 52.6% (10) started with capecitabine, 26.3% (five) combined with oxaliplatin, 15.8% (three) started …
…in the pivotal SUNLIGHT trial, supporting the benefit of adding bevacizumab to trifluridine/tipiracil in real-world practice. Safety profil…
… 20% and 30% of patients, respectively, and 90% achieved higher ustekinumab levels post-intervention.Conclusion and Relevance Although ADA …
…ime since severe asthma diagnosis was 6 (±6) years, with a mean omalizumab treatment persistence of 5 (±4) years and a Dm of 477 (±115) mg…